Currently, several GLP-1 receptor agonists, including Dulaglutide (Trulicity), Exenatide (Byetta), and Liraglutide (Victoza), are used to treat type 2 diabetes
Sources Swissmedic: Warning about the illegal medicinal product Lemon Bottle lipolysis solution FDA: Using Fat-Dissolving Injections That Are Not FDA Approved Can Be Harmful S3 Guideline: Prevention and Treatment of Obesity, AWMF Wegovy EPAR, European Medicines Agency Mounjaro EPAR, European Medicines Agency
The right choice depends on individual goals, medical history, and tolerance for injection therapy
When someone drops 40 or 60 pounds, the jaw underneath starts showing itself in ways it never did before
Linear peptide structure distinguishes it from cyclic Melanotan 2
JM expressed a preference for once-weekly injection, and, clinically, an agent with demonstrated cardiovascular risk reduction and efficacy for weight loss are indicated